PTCT
NASDAQ
US
PTC Therapeutics, Inc. - Common Stock
$67,77
▼ $-0,98
(-1,43%)
Vol 483K
9
Score de Qualité
ok
Analyse approfondie
1/5
fail
CA ✓
RN ✗
>IPO ✗
Cap. boursière
$6.1B
P/E
8,1
ROE
-351,9%
Marge
42,3%
D/E
84892,86
Beta
0,47
52W
$36–$88
Consensus Wall Street
21 analystes · Avr 20264
Achat fort
10
Achat
6
Conserver
1
Vente
0
Vente forte
66,7%
Note d'achat
Graphique de Prix
Actions similaires
RYTM
Rhythm Pharmaceuticals Inc
$7.1B
SRRK
Scholar Rock Holding Corp
$4.5B
COGT
Cogent Biosciences Inc
$5.4B
CGON
CG Oncology Inc
$3.3B
MIRM
Mirum Pharmaceuticals Inc
$4.1B
ERAS
Erasca Inc
$1.1B
CAI
Caris Life Sciences Inc
$7.6B
CELC
Celcuity Inc
$4.6B
TGTX
TG Therapeutics Inc
P/E 10,6
$4.7B
APLS
Apellis Pharmaceuticals Inc
P/E 70,7
$3.2B
Bénéfices
Taux de dépassement: 75,0%| Trimestre | BPA est. | BPA réel | Surprise |
|---|---|---|---|
| Déc 2025 | $0,04 | $-1,67 | $-1,71 |
| Sep 2025 | $-1,40 | $0,20 | +$1,60 |
| Jui 2025 | $-1,08 | $-0,83 | +$0,25 |
| Mar 2025 | $-0,22 | $10,04 | +$10,26 |
Tendance des fondamentaux
| Métrique | 2025-06-30 | 2025-09-02 | 2025-10-02 | 2025-11-03 | 2025-12-03 | 2026-01-02 |
|---|---|---|---|---|---|---|
| ROE (TTM) | — | -351.9% | -351.9% | -351.9% | -351.9% | -351.9% |
| P/E (TTM) | 6.15 | 6.26 | 7.75 | 8.62 | 8.38 | 8.11 |
| Net Margin | -36.2% | 35.6% | 35.6% | 35.6% | 42.2% | 42.2% |
| Gross Margin | 93.6% | 97.1% | 97.1% | 97.1% | 96.8% | 96.8% |
| D/E Ratio | — | 84892.86 | 84892.86 | 84892.86 | 84892.86 | 84892.86 |
| Current Ratio | 3.62 | 3.62 | 3.62 | 3.62 | 2.32 | 2.32 |
Ratios clés
ROA (TTM)
31,2%
P/S (TTM)
3,43
P/B
1877,3
EPS (TTM)
$8,53
CF/Share
$-6,03
Croiss. CA 3A
+14,4%
52W High
$87,50
52W Low
$35,95
$35,95
Plage 52 semaines
$87,50
Як PTCT виглядає на тлі конкурентів у Biotechnology?
Група порівняння: Micro-cap Biotechnology (All) · 528 компаній
Оцінка PTCT vs аналоги Biotechnology
Ratio P/E
8,1
▼
57%
en dessous
pairs
(18,8)
vs Pairs
vs Industrie
Sous-évalué
Ratio P/S
3,4
▼
73%
en dessous
pairs
(12,9)
vs Pairs
vs Industrie
Sous-évalué
Ratio P/B
1877,3
▲
76212%
au-dessus
pairs
(2,5)
vs Pairs
vs Industrie
Surévalué
Rendement dividende
—
▼
0%
en dessous
pairs
(0,0%)
vs Pairs
vs Industrie
Faible rendement
Прибутковість PTCT vs аналоги Biotechnology
ROE
-351,9%
▼
423%
en dessous
pairs
(-67,3%)
vs Pairs
vs Industrie
Faible
Net margin
42,3%
▲
115%
au-dessus
pairs
(-286,8%)
vs Pairs
vs Industrie
Sous la moyenne
Marge brute
96,8%
▲
23%
au-dessus
pairs
(78,6%)
vs Pairs
vs Industrie
Faible
ROA
31,2%
▲
167%
au-dessus
pairs
(-46,7%)
vs Pairs
vs Industrie
Premier rang
Фінансове здоровʼя PTCT vs аналоги Biotechnology
Ratio D/E
84892,9
▼
0%
en dessous
pairs
(0,0)
vs Pairs
vs Industrie
Fort endettement
Ratio de liquidité
2,3
▼
48%
en dessous
pairs
(4,4)
vs Pairs
vs Industrie
Faible liquidité
Beta
0,5
▼
51%
en dessous
pairs
(1,0)
vs Pairs
vs Industrie
Plus volatil
Радар фундаменталів PTCT
PTCT
Médiane des pairs
Industrie
PTCT прибутковість vs борг
Taille = capitalisation · X = marge nette · Y = Ratio D/E
PTCT vs аналоги: ключові метрики
Signaux Liés
Dernier avis AI
Grok
SKIP
Price action shows a steady decline from the November 2025 peak of around $80 to the current $64.67, with recent weeks trading sideways to lower between $66-70 without clear reversal signals or increasing volume on up days, making this not …
Mar 24, 2026Dernières actualités
Pas encore d'actualités liées